Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes
Authors:
- Piotr RutkowskiPRPiotr Rutkowski
- Zbigniew I. NoweckiZNZbigniew I. Nowecki
- Wirginiusz DziewirskiWDWirginiusz Dziewirski
- Marcin ZdzienickiMZMarcin Zdzienicki
- Andrzej PieñkowskiAPAndrzej Pieñkowski
- Maciej SalamachaMSMaciej Salamacha
- Wanda MichejWMWanda Michej
- Slawomir TrepkaSTSlawomir Trepka
- Elzbieta BylinaEBElzbieta Bylina
- Wlodzimierz RukaWRWlodzimierz Ruka
- 1 June 2010
- journal article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 36 (6) , 868-876
Abstract
O 2007 with radical therapeutic lymph node dissection (LND; stage IIIB, C) due to clinically palpable and pathologically confirmed lymph node metastases (229 axillary; 230 ilioinguinal). The median follow-up was 49 months. RESULTS LND was performed in 59 cases (12.9%; 29 men, 30 women) due to MUP nodal metastases, including 33 axillary (14.4%) and 26 ilioinguinal (11.3%). In the MUP group, the 3- and 5-year survival rates were 48% and 41%, respectively. Similar rates were observed in patients with KPM, even with matched-pair analyses. Established prognostic factors (number of metastatic nodes, p=.005; extracapsular extension of metastases, p=.002) influenced survival in the MUP group. Relapses occurred in 31 (53%) and 299 (74.7%) cases in the MUP and KPM groups, respectively. CONCLUSIONS Survival rates in the MUP and KPM groups were similar, and the same prognostic factors affected both. Thus, all MUP cases should be treated as standard stage III melanomas. The authors have indicated no significant interest with commercial supporters....Keywords
This publication has 19 references indexed in Scilit:
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging SystemJournal of Clinical Oncology, 2001
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanomaBritish Journal of Surgery, 2000
- Regional nodal surgery for melanoma impacts recurrence rates and survival.Annals of Surgical Oncology, 2000
- Melanoma of unknown primary siteCancer, 1997
- Surgical Management of Regional Lymph Nodes in Patients with Melanoma Experience with 4682 PatientsAnnals of Surgery, 1994
- The prognosis of patients with stage III melanoma prospective long-term study of 286 patients of the fachklinik hornheideCancer, 1993
- Lymphadenectomy in the Management of Stage I Malignant Melanoma: A Prospective Randomized StudyMayo Clinic Proceedings, 1986
- Prognosis of skin melanoma with regional node metastases (stage II)Journal of Surgical Oncology, 1984
- Malignant melanoma with unknown primary siteJournal of Surgical Oncology, 1982